Why overuse of antibiotics in COVID-19 could have lasting impact in health care

  26 June 2020

A leading Canadian microbiologist is sounding an alarm about overuse of precious antibiotics among the world’s more than 8.7 million cases of COVID-19.

So many people have been seriously sickened by COVID-19 that they need to be cared for in hospital, such as with oxygen. Doctors commonly prescribe antibiotics for people with COVID-19 in hospital.

Eric Brown, a professor at the McMaster University’s Institute of Infectious Disease Research, has concerns about how COVID-19 could drive up antibiotic resistance in bacteria that aren’t killed by standard drugs.

“The biggest concern is for those who have COVID-19 who maybe don’t need an antibiotic,” he said.

Canadian infectious disease physicians say guidelines suggest a limited role for antibiotics in COVID-19 cases. Once it’s clear that the person has COVID and there’s no bacterial infection, then the antibiotic treatments should be stopped to avoid encouraging another infection in the same patient.

Further reading: CBC
Author(s): Amina Zafar
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!